Related Experiment Video
Updated: Jul 10, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Challenges in telemedicine equivalence studies.
Eve-Lynn Nelson1, Susan Palsbo
1Kansas University Medical Center, 2012 Wahl Annex, MS 1048, 3901 Rainbow Blvd. Kansas City, KS 66160, USA.
Evaluation and Program Planning
|October 24, 2007
Summary
This study evaluated diagnostic accuracy in telemedicine using randomized controlled trials across five specialty clinics. Findings support the reliability of interactive televideo for accurate remote diagnoses, addressing key research design limitations.
Area of Science:
- Health Services Research
- Medical Informatics
- Telemedicine
Background:
- Growing adoption of telemedicine necessitates rigorous evaluation of diagnostic accuracy.
- Previous studies on diagnostic equivalency in telehealth often lack robust research designs.
- Interactive televideo is a key technology in modern telehealth delivery.
Purpose of the Study:
- To assess the diagnostic accuracy of interactive televideo in real-world clinical settings.
- To address methodological shortcomings in prior telehealth diagnostic equivalency research.
- To identify and discuss critical decision points in designing telehealth diagnostic studies.
Main Methods:
- Conducted randomized controlled trials (RCTs) within two operational telehealth programs.
- Evaluated diagnostic equivalency across five specialty clinics: physical therapy, speech therapy, ambulatory pediatrics, child psychiatry, and developmental disabilities.
- Focused on methodological considerations including study design, participant selection, technology, and evaluation metrics.
Main Results:
- Demonstrated diagnostic equivalency in telehealth specialty clinics through rigorous RCTs.
- Highlighted common challenges and decision points faced by research teams implementing telehealth diagnostic studies.
- Provided evidence supporting the accuracy of diagnoses made via interactive televideo.
Conclusions:
- Telemedicine, specifically interactive televideo, can achieve accurate diagnoses comparable to in-person evaluations.
- The study offers a strong methodological framework for future telehealth diagnostic accuracy research.
- Methodological considerations discussed are applicable across various telehealth technologies.
Related Concept Videos
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...